SMMT · Summit Therapeutics Inc. · Documents
$15.46
+0.13 (+0.85%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Jul 23, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 23, 2026
Market Cap
$12.32B
Shares
797.75M
Volume · Oct 28
764.78K
Avg daily vol (3M)
6.06M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-03-09 | — | |
| 10-K | — | 2023-03-09 | 2022-12-31 | |
| 8-K | — | 2023-03-03 | 2023-03-01 | |
| 8-K | — | 2023-02-23 | — | |
| 8-K | — | 2023-01-30 | — | |
| 8-K | — | 2023-01-27 | — | |
| S-3/A | — | 2023-01-23 | — | |
| 8-K | — | 2023-01-20 | 2023-01-16 | |
| 8-K | — | 2023-01-09 | 2023-01-06 | |
| 8-K | — | 2022-12-27 | 2022-12-22 | |
| 10-K/A | — | 2022-12-21 | 2021-12-31 | |
| S-3 | — | 2022-12-21 | — | |
| 8-K | — | 2022-12-21 | — | |
| DEF 14A | — | 2022-12-13 | 2023-01-06 | |
| 8-K | — | 2022-12-06 | 2022-12-05 | |
| PRE 14A | — | 2022-11-29 | — | |
| 8-K | — | 2022-11-17 | 2022-11-15 | |
| 10-Q | — | 2022-11-09 | 2022-09-30 | |
| 8-K | — | 2022-11-09 | — | |
| 8-K | — | 2022-10-20 | — | |
| 8-K | — | 2022-10-04 | 2022-09-28 | |
| 8-K | — | 2022-10-03 | 2022-09-28 | |
| 8-K | — | 2022-08-16 | 2022-08-15 | |
| 8-K | — | 2022-08-11 | — | |
| 10-Q | — | 2022-08-11 | 2022-06-30 | |
| 8-K | — | 2022-08-09 | — | |
| 8-K | — | 2022-08-02 | — | |
| 8-K | — | 2022-07-29 | 2022-07-27 | |
| 8-K | — | 2022-07-26 | 2022-07-25 | |
| 8-K | — | 2022-07-18 | — | |
| 8-K | — | 2022-07-14 | — | |
| DEF 14A | — | 2022-07-06 | — | |
| PRE 14A | — | 2022-06-24 | 2022-07-27 | |
| 8-K | — | 2022-06-22 | 2022-06-16 | |
| 8-K | — | 2022-06-22 | — | |
| DEFA14A | — | 2022-06-03 | — | |
| 8-K | — | 2022-06-01 | — | |
| 10-Q | — | 2022-05-11 | 2022-03-31 | |
| 8-K | — | 2022-05-11 | — | |
| DEF 14A | — | 2022-04-29 | 2022-06-15 | |
| 10-K | — | 2022-03-17 | 2021-12-31 | |
| 8-K | — | 2022-03-17 | — | |
| 8-K | — | 2022-03-11 | 2022-03-10 | |
| 8-K | — | 2022-02-09 | — | |
| 8-K | — | 2022-01-25 | — | |
| 8-K | — | 2022-01-12 | 2022-01-07 | |
| 8-K | — | 2021-12-20 | — | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 8-K | — | 2021-11-15 | — | |
| 8-K | — | 2021-11-03 | — |
Showing 101–150 of 204 filings
Key facts
CIK
1599298
CUSIP
86627T108
13F (30d)
48 filings
48 filers
Visit website
Investor relations